Investing Profile
Clay Thorp
Your Intro Paths to Clay Thorp
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Clay is a member of
University of North Carolina at Chapel Hill Network
80 CONNECTIONS
Harvard Kennedy School Network
55 CONNECTIONS
Intel Capital Network
40 CONNECTIONS
Intel Capital Network
40 CONNECTIONS
Intel Capital Network
40 CONNECTIONS
Find Clay Thorp on
cbCurrent Investing Position
Hatteras Venture Partners General Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
15
Current Fund Size
$94M
Clay Thorp is on these Sector & Stage Rankings
Clay Thorp's Investments On Record (10)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
CREATE Medicines | Series BMay 2026$120M Series AMay 2023$73M | $200M |
Ten63 Therapeutics | Series UnknownFeb 2026 Series AMay 2023$16M | $16M |
GeneCentric Therapeutics | Series CJun 2025$8M | $8M |
Rodin Therapeutics | Series CSep 2017$27M | $64M |
Lysosomal Therapeutics | Series AFeb 2015$20M SeedMay 2014$5M | $25M |
Clearside Biomedical | Series BSep 2014$16M Series AFeb 2013$8M Series AJan 2012$4M | $28M |
Curoverse | SeedDec 2013$2M | $2M |
Pathfinder Therapeutics | Series AOct 2008$5M | $5M |
Clay Thorp's Experience
Co-Director Intel CapitalPresent
Director of Corporate Development Intel CapitalPresent
Director, Corporate Development Intel CapitalPresent
Chairman Intel CapitalPresent
General Partner Hatteras Venture PartnersPresent
General Partner Intel CapitalPresent
Clay Thorp's Education
University of North Carolina at Chapel Hill BA Math and Art History
Harvard Kennedy School Master’s Degree Public Policy - Business/Government concentration
Investors who invest with Clay Thorp
Sign in with Google →Scouts & Angels Affiliated With Clay Thorp
Sign in with Google →